BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18504583)

  • 21. [Myelofibrosis and cryptogenetic osteosclerosis. A case of myelofibrosis with skin localizations, ascites and repeated hematemesis].
    Gentili M
    Policlinico Med; 1968; 75(1):1-33. PubMed ID: 5739279
    [No Abstract]   [Full Text] [Related]  

  • 22. Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin.
    Bock O; Loch G; Schade U; Büsche G; Wasielewski R; Wiese B; Kreipe H
    Br J Haematol; 2005 Jul; 130(1):76-82. PubMed ID: 15982347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of Endothelin-1 in a Syndrome of Myelofibrosis and Osteosclerosis.
    Yachoui R; Kristianto J; Sitwala K; Blank RD
    J Clin Endocrinol Metab; 2015 Nov; 100(11):3971-4. PubMed ID: 26358171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A rare cause of variceal bleeding].
    Naderi J; Lohse AW; Galle PR; Schramm C
    Z Gastroenterol; 2010 Oct; 48(10):1215-8. PubMed ID: 20886427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D receptor-mediated skewed differentiation of macrophages initiates myelofibrosis and subsequent osteosclerosis.
    Wakahashi K; Minagawa K; Kawano Y; Kawano H; Suzuki T; Ishii S; Sada A; Asada N; Sato M; Kato S; Shide K; Shimoda K; Matsui T; Katayama Y
    Blood; 2019 Apr; 133(15):1619-1629. PubMed ID: 30718230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Case of intraspinal epidural tumor developing after systemic mastocytosis with marked osteosclerosis and myelofibrosis].
    Ohnishi K; Torimoto Y; Itabashi K; Inamura J; Shindo M; Ikuta K; Sato K; Kohgo Y
    Rinsho Ketsueki; 2005 Oct; 46(10):1146-51. PubMed ID: 16440779
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal segmental glomerulosclerosis in a patient with prefibrotic primary myelofibrosis.
    Bohra GK; Meena DS; Bajpai N; Purohit A
    BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29728434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alpha interferon treatment of chronic myeloproliferative disease associated thrombocytosis].
    Remes K; Pelliniemi TT
    Duodecim; 1993; 109(11):983-9. PubMed ID: 8062671
    [No Abstract]   [Full Text] [Related]  

  • 29. Histomorphometric analysis of sclerotic bone from idiopathic myeloid metaplasia (nine cases).
    Coindre JM; Reiffers J; Goussot JF; De Mascarel A; Broustet A
    J Pathol; 1984 Nov; 144(3):163-9. PubMed ID: 6502295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Laboratory diagnosis of idiopathic myelofibrosis. Review of the literature and presentation of 15 cases].
    Milanesi B; Pirali F
    Minerva Med; 1981 Sep; 72(34):2265-72. PubMed ID: 7290453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are polycythemia vera, essential thrombocytosis, and primary myelofibrosis 1, 2, or 3 diseases?
    Spivak JL
    Leukemia; 2021 Jul; 35(7):1890-1893. PubMed ID: 33911177
    [No Abstract]   [Full Text] [Related]  

  • 32. Discrepancies of applying primary myelofibrosis prognostic scores for patients with post polycythemia vera/essential thrombocytosis myelofibrosis.
    Gowin K; Coakley M; Kosiorek H; Mesa R
    Haematologica; 2016 Oct; 101(10):e405-e406. PubMed ID: 27354022
    [No Abstract]   [Full Text] [Related]  

  • 33. [Bone changes in the legs caused by disorders of venous and lymphatic circulation].
    Bercu G; Lupu A
    Ann Dermatol Syphiligr (Paris); 1968; 95(4):411-3. PubMed ID: 5705093
    [No Abstract]   [Full Text] [Related]  

  • 34. Increased serum thrombopoietin concentration in systemic sclerosis associated with myelofibrosis and thrombocytosis.
    Ozturk MA; Haznedaroglu S; Karaaslan Y; Goker B; Haznedaroglu IC
    Joint Bone Spine; 2006 Jan; 73(1):122-3. PubMed ID: 16256396
    [No Abstract]   [Full Text] [Related]  

  • 35. Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG).
    Wang JC; Hemavathy K; Charles W; Zhang H; Dua PK; Novetsky AD; Chang T; Wong C; Jabara M
    Exp Hematol; 2004 Oct; 32(10):905-10. PubMed ID: 15504545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myelofibrosis presenting as splenic tumor.
    Macumber C; Phan TG; Young GA; Selby WS
    Dig Dis Sci; 1999 Sep; 44(9):1817-22. PubMed ID: 10505720
    [No Abstract]   [Full Text] [Related]  

  • 37. Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.
    Arora B; Mesa R; Tefferi A
    Leuk Lymphoma; 2004 Dec; 45(12):2373-86. PubMed ID: 15621750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The natural history of chronic non-leukaemic myelosis.
    Hickling RA
    Q J Med; 1968 Apr; 37(146):267-79. PubMed ID: 5656158
    [No Abstract]   [Full Text] [Related]  

  • 39. Pegylated interferon α2a induces complete remission of acute myeloid leukemia in a postessential thrombocythemia myelofibrosis permitting allogenic stem cell transplantation.
    Dagorne A; Douet-Guilbert N; Quintin-Roue I; Guillerm G; Couturier MA; Berthou C; Ianotto JC
    Ann Hematol; 2013 Mar; 92(3):407-9. PubMed ID: 22941306
    [No Abstract]   [Full Text] [Related]  

  • 40. MDS/MPN with ring sideroblasts and thrombocytosis masquerading as prefibrotic/early primary myelofibrosis.
    Xu Z
    Blood; 2017 Feb; 129(5):657. PubMed ID: 28153839
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.